SR

Shazidur Rohman

Active Director Director DIN 11189059
DIN 11189059 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Shazidur Rohman

Data last updated:

Shazidur Rohman is a Director at Infyzer Pharmaceutical Private Limited (since 2025). The company operates in Pharma. Infyzer Pharmaceutical Private Limited reported revenue of ₹5,247 (FY 2024).

DIN 11189059
Primary Designation Director
Industry Pharma
First Appointment 07 Jul 2025
Oldest Company Age 3 yrs
Largest company Infyzer Pharmaceutical Private Limited · ₹5,247 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20252023₹5,247 (FY 2024)Active

Board colleagues of Shazidur Rohman

NameDINCompanyDesignation
Rahul Anam10228352Infyzer Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Infyzer Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Shazidur Rohman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shazidur Rohman

Shazidur Rohman currently holds 1 directorship: Infyzer Pharmaceutical Private Limited (Director, since 07 Jul 2025, revenue ₹5,247 (FY 2024)).

Shazidur Rohman was first appointed on 07 Jul 2025 as Director at Infyzer Pharmaceutical Private Limited.

The current boards of Shazidur Rohman's companies include Rahul Anam (Infyzer Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available